|
24/03/2023
|
11:31
|
Results of General Meeting
|
RNS
|
|
10/03/2023
|
17:52
|
Further re: Notice of General Meeting
|
RNS
|
|
08/03/2023
|
07:00
|
Posting of Circular and Notice of General Meeting
|
RNS
|
|
17/02/2023
|
07:00
|
Holding(s) in Company
|
RNS
|
|
16/02/2023
|
07:00
|
Holding(s) in Company
|
RNS
|
|
15/02/2023
|
14:49
|
Holding(s) in Company
|
RNS
|
|
15/02/2023
|
13:36
|
Holding(s) in Company
|
RNS
|
|
15/02/2023
|
13:26
|
Holding(s) in Company
|
RNS
|
|
15/02/2023
|
08:05
|
Closing of $6.0m Private Placement & Broker Change
|
RNS
|
|
09/02/2023
|
17:10
|
Private Placement Raising US$6.0 million
|
RNS
|
|
03/02/2023
|
09:57
|
Receipt of NASDAQ Notice
|
RNS
|
|
23/01/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
23/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
23/01/2023
|
12:00
|
Result of General Meeting
|
RNS
|
|
16/01/2023
|
11:24
|
Holding(s) in Company
|
RNS
|
|
12/01/2023
|
07:00
|
Planned Dose Escalation in MTX-110 Phase 1 Study
|
RNS
|
|
06/01/2023
|
07:00
|
Posting of Circular and Notice of General Meeting
|
RNS
|
|
19/12/2022
|
12:06
|
Holding(s) in Company
|
RNS
|
|
19/12/2022
|
10:48
|
Holding(s) in Company
|
RNS
|
|
19/12/2022
|
07:00
|
Closing of Offering, Revised Terms, AIM & Webinar
|
RNS
|
|
14/12/2022
|
14:05
|
Second Price Monitoring Extn
|
RNS
|
|
14/12/2022
|
14:00
|
Price Monitoring Extension
|
RNS
|
|
13/12/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
13/12/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
13/12/2022
|
15:22
|
Proposed Acquisition of Bioasis Technologies Inc
|
RNS
|
|
14/11/2022
|
07:00
|
First Patient Enrolled in Phase 1 Study of MTX-110
|
RNS
|
|
18/10/2022
|
07:00
|
Receipt of NASDAQ Notification
|
RNS
|
|
20/09/2022
|
11:51
|
Holding(s) in Company
|
RNS
|
|
14/09/2022
|
13:57
|
ADR Ratio Change
|
RNS
|
|
14/09/2022
|
07:00
|
Interim results for the six months to 30 June 2022
|
RNS
|
|
21/06/2022
|
07:00
|
MTX110 Development for the Treatment of Glioma
|
RNS
|
|
20/06/2022
|
17:58
|
Directorate Change
|
RNS
|
|
20/06/2022
|
14:33
|
Result of 2022 Annual General Meeting
|
RNS
|
|
10/06/2022
|
07:00
|
Retirement of Chairman and Proposed New Chairman
|
RNS
|
|
10/06/2022
|
07:00
|
MTX110 Study to be Presented at ISPNO 2022
|
RNS
|
|
01/06/2022
|
12:23
|
Fast Track Designation for MTX110 Development
|
RNS
|
|
24/05/2022
|
11:09
|
Posting of Annual Report & Notice of AGM
|
RNS
|
|
27/04/2022
|
13:00
|
Issue of Equity for Employee Share Incentive Plan
|
RNS
|
|
26/04/2022
|
07:00
|
Results for the Year Ended 31 December 2021
|
RNS
|
|
14/04/2022
|
12:37
|
Receipt of NASDAQ Notice
|
RNS
|
|
17/03/2022
|
07:00
|
Exercise of Warrants and Issue of Equity
|
RNS
|
|
09/03/2022
|
07:00
|
R&D collaboration with Janssen on second molecule
|
RNS
|
|
08/03/2022
|
09:30
|
Appointment of Nominated and Financial Adviser
|
RNS
|
|
09/02/2022
|
13:53
|
Holding(s) in Company
|
RNS
|
|
18/01/2022
|
16:18
|
Holding(s) in Company
|
RNS
|
|
17/01/2022
|
07:00
|
Extension of Janssen collaboration re Q-Sphera
|
RNS
|
|
07/01/2022
|
17:37
|
Holding(s) in Company
|
RNS
|
|
13/12/2021
|
09:43
|
IND Application for MTX110 Study in GBM Effective
|
RNS
|
|
03/12/2021
|
07:00
|
Midatech presenting at MelloMonday
|
RNS
|
|
24/11/2021
|
07:00
|
Midatech presenting at the Shares/AJ Bell Webinar
|
RNS
|